Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-29 · accession 0001171843-25-003587 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-02 | 2025-05-29 | EDSA | Brooks Michael J | Pres | A - Grant | $0.00 | +207.2K | 224.9K | +1,173% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-05-29 | A | A | 207,201 | $0.00 | 224,870 | D | — | — | (F1) Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 142,592 shares shall vest in equal proportions over eighteen (18) months, commencing on the grant date and (ii) 64,609 shares vest in equal proportions over thirty-six (36) months, commencing on the grant date. (F2) Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023. |